logo
Share SHARE
FONT-SIZE Plus   Neg

DexCom Names Kevin Sayer COO - Quick Facts

DexCom, Inc. (DXCM), a medical device company, said it has appointed Kevin Sayer, currently the company's president, as its chief operating officer or COO.

As President, Sayer is responsible for the firm's research and development, manufacturing, clinical, regulatory and finance functions. He will continue to lead these groups, and with the additional responsibility as COO, Sayer will also lead the company's sales, marketing, and other core commercial functions.

DexCom noted that Sayer will continue to report to Terry Gregg, chief executive officer of the company.

Sayer has served as DexCom's president since June 2011, and as a board member since November 2007.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
ConAgra Foods Inc. (CAG) reported a net income attributable to the company for the fourth quarter ended May 29, 2016 that declined 43.8 percent from last year. Adjusted earnings per share from continuing operations decreased 5% from the prior year. The comparable earnings per share decline reflected... Another busy month on the FDA calendar has gone by but not without its fair share of hurrahs and heartaches. This is not unexpected, given the uncertainties characterizing drug development and approval processes, which in turn manifest as volatility in stocks belonging to the biotech space. German sporting goods giant Adidas Group (ADDYY.PK, ADDDF.PK) extended its long-term relationship with rapper and fashion designer Kanye West, launching a new line of Yeezy brand products for all genders, the company stated. adidas + Kanye West offers Yeezy branded footwear, apparel and accessories for all genders. Under the deal, West will join with adidas team to lead the development...
comments powered by Disqus
Follow RTT